Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

790
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
Ascites01:19

Ascites

47
DefinitionAscites is the buildup of fluid inside the peritoneal cavity. It occurs when fluid moves out of the vascular system faster than the peritoneal lymphatics can remove it. This fluid shift is most commonly seen in liver cirrhosis but can also appear in several other systemic disorders.EtiologyCirrhosis remains the leading cause of ascites. Other conditions that can contribute include:Heart failureConstrictive pericarditisAbdominal cancersNephrotic syndromeSevere protein–calorie...
47
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

30
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet...
30
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

3.0K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.0K
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

40
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
40
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

4.0K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
4.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating incidence and mortality trends of early-onset colorectal cancer and adenoma in Belgium.

ESMO gastrointestinal oncology·2026
Same author

Uniformity of body weight in growing pigs is persistent during growth but affected by sow- and litter-related factors.

Animal : an international journal of animal bioscience·2025
Same author

How to assess litter uniformity in pigs: comparing metrics and investigating associations with sow and litter factors.

Animal : an international journal of animal bioscience·2025
Same author

The value of using multilevel performances (from recreational to international) to the genetic evaluation for show jumping performance in Warmblood horses.

Animal : an international journal of animal bioscience·2025
Same author

Decreased incidence and shift in stage distribution for colorectal cancers in Belgium during the COVID-19 pandemic.

Acta gastro-enterologica Belgica·2025
Same author

Genetic factors of equine osteochondrosis and fetlock osteochondral fragments: A scoping review - Part 2.

Veterinary journal (London, England : 1997)·2024

Related Experiment Video

Updated: May 2, 2026

A Revised Method for Inducing Secondary Lymphedema in the Hindlimb of Mice
09:50

A Revised Method for Inducing Secondary Lymphedema in the Hindlimb of Mice

Published on: November 2, 2019

7.6K

Chronic progressive lymphoedema in draught horses.

K de Keyser1, S Janssens, N Buys

  • 1Livestock Genetics, Department of Biosystems, KU Leuven, Heverlee (Leuven), Belgium.

Equine Veterinary Journal
|March 6, 2014
PubMed
Summary

Chronic progressive lymphoedema in draught horses causes limb swelling and skin issues. Further research is needed for better diagnostics and treatments for this costly condition.

Keywords:
chronic progressive lymphoedemaclinical signsdraught horsehorsemolecular geneticsquantitative genetics

More Related Videos

A Murine Tail Lymphedema Model
04:38

A Murine Tail Lymphedema Model

Published on: February 10, 2021

5.9K
Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting
07:36

Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting

Published on: May 1, 2015

13.8K

Related Experiment Videos

Last Updated: May 2, 2026

A Revised Method for Inducing Secondary Lymphedema in the Hindlimb of Mice
09:50

A Revised Method for Inducing Secondary Lymphedema in the Hindlimb of Mice

Published on: November 2, 2019

7.6K
A Murine Tail Lymphedema Model
04:38

A Murine Tail Lymphedema Model

Published on: February 10, 2021

5.9K
Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting
07:36

Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting

Published on: May 1, 2015

13.8K

Area of Science:

  • Veterinary Medicine
  • Equine Health
  • Dermatology

Background:

  • Chronic progressive lymphoedema (CPL) is a multifactorial disorder affecting draught horses, primarily impacting the lower limbs.
  • Clinical signs include progressive skin deterioration, swelling, and deformation, with significant economic impact.
  • First reported in the early 20th century, CPL was recognized as a distinct syndrome in 2003, prompting increased research.

Purpose of the Study:

  • To summarize and evaluate the current state of knowledge regarding chronic progressive lymphoedema in draught horses.
  • To identify gaps in understanding and areas for future research in CPL.

Main Methods:

  • Literature review and synthesis of existing research on chronic progressive lymphoedema.
  • Evaluation of clinical signs, pathogenesis, prevalence, and economic impact.
  • Assessment of current diagnostic techniques and treatment options.

Main Results:

  • CPL is characterized by progressive limb swelling and skin changes, with high prevalence in certain breeds.
  • The exact pathogenesis of CPL remains incompletely understood.
  • Current treatments for CPL are symptomatic and noncurative, highlighting limitations in management.

Conclusions:

  • Improved diagnostic techniques for chronic progressive lymphoedema are essential.
  • Development of selection tools to mitigate the genetic or environmental factors contributing to CPL is needed.
  • Further research into the pathogenesis and effective treatments for CPL is critical for equine welfare and industry sustainability.